5395512026-01-012026-03-315395512026-03-315395512025-03-315395512025-04-012026-03-315395512026-01-012026-03-31in-capmkt:OtherExpenses1Member5395512026-01-012026-03-31in-capmkt:OtherExpenses2Member5395512025-04-012026-03-31in-capmkt:OtherExpenses1Member5395512025-04-012026-03-31in-capmkt:OtherExpenses2Member5395512026-03-31OtherNoncurrentFinancialAssetsDomain15395512026-03-31OtherNoncurrentAssetsDomain15395512026-03-31OtherNoncurrentAssetsDomain25395512026-03-31OtherNoncurrentAssetsDomain35395512026-03-31OtherNoncurrentAssetsDomain45395512026-03-31OtherCurrentFinancialAssetsDomain15395512026-03-31OtherCurrentAssetsDomain15395512026-03-31OtherCurrentAssetsDomain25395512026-03-31OtherNoncurrentFinancialLiabilitiesDomain15395512026-03-31OtherNoncurrentFinancialLiabilitiesDomain25395512026-03-31OtherNoncurrentLiabilitiesDomain15395512026-03-31OtherCurrentFinancialLiabilitiesDomain15395512026-03-31OtherCurrentFinancialLiabilitiesDomain25395512026-03-31OtherCurrentLiabilitiesDomain15395512026-01-012026-03-31in-capmkt:ReportableSegments1Member5395512026-01-012026-03-31in-capmkt:ReportableSegments2Member5395512026-01-012026-03-31in-capmkt:ReportableSegments3Member5395512025-04-012026-03-31in-capmkt:ReportableSegments1Member5395512025-04-012026-03-31in-capmkt:ReportableSegments2Member5395512025-04-012026-03-31in-capmkt:ReportableSegments3Member5395512026-01-012026-03-31in-capmkt:ReportableSegments1Member5395512026-01-012026-03-31in-capmkt:ReportableSegments2Member5395512026-01-012026-03-31in-capmkt:ReportableSegments3Member5395512025-04-012026-03-31in-capmkt:ReportableSegments1Member5395512025-04-012026-03-31in-capmkt:ReportableSegments2Member5395512025-04-012026-03-31in-capmkt:ReportableSegments3Member5395512026-01-012026-03-31in-capmkt:ReportableSegments1Member5395512026-03-31in-capmkt:ReportableSegments1Member5395512026-01-012026-03-31in-capmkt:ReportableSegments2Member5395512026-03-31in-capmkt:ReportableSegments2Member5395512026-01-012026-03-31in-capmkt:ReportableSegments3Member5395512026-03-31in-capmkt:ReportableSegments3Member5395512026-01-012026-03-31in-capmkt:ReportableSegments1Member5395512026-03-31in-capmkt:ReportableSegments1Member5395512026-01-012026-03-31in-capmkt:ReportableSegments2Member5395512026-03-31in-capmkt:ReportableSegments2Member5395512026-01-012026-03-31in-capmkt:ReportableSegments3Member5395512026-03-31in-capmkt:ReportableSegments3Member5395512026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15395512026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25395512025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15395512025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25395512026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15395512026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25395512026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss35395512025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15395512025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25395512025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss35395512026-01-012026-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares539551NHNOTLISTEDINE410P01011Narayana Hrudayalaya Ltd.Main BoardEquity2025-04-012026-03-312026-05-222026-05-18INRMillionsQuarterlyFourth quarterMulti segment2026-05-2215:30:002026-05-2219:00:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31UnauditedConsolidated259380600002922900002623035000005246190000-179900000748885000091285000015377200008283090000232888000002941550000-1800002941370000760940000-119870000641070000-199700002280330000-331900007220000-40410000022399200009650200003204940000223878000011400003204580000115000020436100001011.2211.22-0.2-0.211.0211.020.01290.02060.042The amounts of Rs. (19.97) million and Rs. (55.79) million disclosed under Point No. 10 represent our share of loss from equity-accounted investees. If these amounts are instead presented under Point No. 15 (being the appropriate tab for presentation in our internal financial statements), only the classification changes. The overall profit figure remains unchanged. <BR> <BR> In other words, this is merely a reclassification from Point No. 10 to Point No. 15 to ensure alignment with our internal financial statement presentation. There is no impact on the total profit as reported in the financials. <BR> 2025-04-012026-03-31AuditedConsolidated78960350000100219000079962540000015603810000-4426800001802981000024374100004478020000296026900006970906000010253480000-50954000097439400001766040000-1824800001583560000-557900008104590000-368900007910000-4480000008059790000196720000010026990000805599000038000001002298000038300002043610000104332897000039.8939.89-0.22-0.2239.6739.670.01290.02360.0497Professional fees to doctors2412090000Other expenses5871000000Professional fees to doctors10987380000Other expenses186153100004526669000026684200000139056000001033011000025094000000132266000009492700006444200002916350000112270000997230000085422680000154529000041426200006556620000770067000013591260000038395800003583075000019453200003932136000000124744040000204361000043328970000453725800002264000045395220000466718200000008982810000556546300007492200003307510000013649400006107630000019886800004351400009886000000103211400002815240000151250600001940820000909790000296850000182725200000079348820000124744040000Other Financial Assets644420000Income tax assets (net)96000000Other non-current assets1154120000Right to use assets8455900000Investment in associates266280000Other Financial Assets3839580000Other current assets1945320000Assets classified as held for sale0Lease liabilities8496200000Other financial liabilities486610000Other non-current liabilities1364940000Lease liabilities1418250000Other financial liabilities1396990000Other current liabilities1940820000Medical and healthcare related services25019740000Unallocated294250000Others1336740000Medical and healthcare related services76886870000Unallocated1007020000Others385650000026650730000817503900001097700004056500002654096000081344740000Medical and healthcare related services4168640000Unallocated294250000Others-599700000Medical and healthcare related services12386220000Unallocated1007020000Others-124190000038631900001215134000091292000024380200000029502700009713320000Medical and healthcare related services103217890000Unallocated18440990000Others30851600001247440400000124744040000Medical and healthcare related services25351660000Unallocated52609950000Others1387210000793488200000793488200002437410000-24947000021189000002317800000-498400000-115220000-2674830000045770200000-2770510000-724900004494530000033086000026469000065644000014620000-2646800000396810000000-10521000045550000-204130000079990600001774300000000015584500000161845500000215448300000000006670000087494300000000000000000000001903100000-6494540000-3653179000000000000294605900002172670000128185000091004000016667000000023429330000308209000052000000313409000044716400007605730000Re-measurement gains/ (losses) on defined benefit plans24460000Equity instruments through other comprehensive income, net-168500007610000Re-measurement gains/ (losses) on defined benefit plans9440000Equity instruments through other comprehensive income, net-22960000-1352000061700003090000Effective portion of gains/ (losses) in cash flow hedges0Effective portion of gains/ (losses) of net investment hedge in a foreign operation-7760000Exchange differences in translating the financial statement of foreign operations971340000963580000Effective portion of gains/ (losses) in cash flow hedges-6900000Effective portion of gains/ (losses) of net investment hedge in a foreign operation-7760000Exchange differences in translating the financial statement of foreign operations19984700001983810000009650200001967200000AuditedtrueDeloitte Haskins & Sells LLPtrue2027-07-31